Median change in bone microarchitectural parameters between baseline and time point C at distal tibia in a subgroup of patients with long-term follow-up and comparison with a control group.
Tibia . | Baseline . | Time C . | Median % increase between baseline and time C, p . | Control group . | Means difference . | p* . |
---|---|---|---|---|---|---|
Tb.vBMD, mgHA/cm3 | 88.8 ± 57.6 | 88.0 ± 49.8 | +2.0, .021 | 174.7 ± 50.5 | −49.6 | <.001 |
Ct.vBMD, mgHA/cm3 | 788.0 ± 120.3 | 840.1 ± 83.0 | +3.4, .049 | 881.6 ± 54.2 | −4.7 | .110 |
Tb.N, 1/mm | 1.12 ± 0.48 | 1.08 ± 0.56 | −0.2, .586 | 1.98 ± 0.42 | −45.4 | <.001 |
Tb.Th, mm | 0.060 ± 0.043 | 0.066 ± 0.032 | −6.7, .524 | 0.074 ± 0.017 | −10.8 | .209 |
Tb.Sp, mm | 1.072 ± 0.700 | 1.195 ± 0.791 | +1.2, .261 | 0.454 ± 0.125 | +163.2 | <.001 |
Tb.BV/TV, % | 6.5 ± 5.3 | 6.7 ± 5.0 | −9.9, .752 | 14.5 ± 4.2 | −53.8 | <.001 |
Ct.Th, mm | 0.71 ± 0.34 | 0.89 ± 0.26 | +13.8, .040 | 1.22 ± 0.32 | −27.0 | .009 |
Tibia . | Baseline . | Time C . | Median % increase between baseline and time C, p . | Control group . | Means difference . | p* . |
---|---|---|---|---|---|---|
Tb.vBMD, mgHA/cm3 | 88.8 ± 57.6 | 88.0 ± 49.8 | +2.0, .021 | 174.7 ± 50.5 | −49.6 | <.001 |
Ct.vBMD, mgHA/cm3 | 788.0 ± 120.3 | 840.1 ± 83.0 | +3.4, .049 | 881.6 ± 54.2 | −4.7 | .110 |
Tb.N, 1/mm | 1.12 ± 0.48 | 1.08 ± 0.56 | −0.2, .586 | 1.98 ± 0.42 | −45.4 | <.001 |
Tb.Th, mm | 0.060 ± 0.043 | 0.066 ± 0.032 | −6.7, .524 | 0.074 ± 0.017 | −10.8 | .209 |
Tb.Sp, mm | 1.072 ± 0.700 | 1.195 ± 0.791 | +1.2, .261 | 0.454 ± 0.125 | +163.2 | <.001 |
Tb.BV/TV, % | 6.5 ± 5.3 | 6.7 ± 5.0 | −9.9, .752 | 14.5 ± 4.2 | −53.8 | <.001 |
Ct.Th, mm | 0.71 ± 0.34 | 0.89 ± 0.26 | +13.8, .040 | 1.22 ± 0.32 | −27.0 | .009 |
Abbreviations: Tb.vBMD, trabecular density; Ct.vBMD, cortical density; Tb.N, trabecular number; Tb.Th, trabecular thickness; Tb.Sp, trabecular separation; Ct.Th, cortical thickness; Tb.BVTV, trabecular bone volume fraction.
*Comparison between time point C in patients with TIO (subgroup analysis of 10 patients with long-term follow-up) and control group.
Median change in bone microarchitectural parameters between baseline and time point C at distal tibia in a subgroup of patients with long-term follow-up and comparison with a control group.
Tibia . | Baseline . | Time C . | Median % increase between baseline and time C, p . | Control group . | Means difference . | p* . |
---|---|---|---|---|---|---|
Tb.vBMD, mgHA/cm3 | 88.8 ± 57.6 | 88.0 ± 49.8 | +2.0, .021 | 174.7 ± 50.5 | −49.6 | <.001 |
Ct.vBMD, mgHA/cm3 | 788.0 ± 120.3 | 840.1 ± 83.0 | +3.4, .049 | 881.6 ± 54.2 | −4.7 | .110 |
Tb.N, 1/mm | 1.12 ± 0.48 | 1.08 ± 0.56 | −0.2, .586 | 1.98 ± 0.42 | −45.4 | <.001 |
Tb.Th, mm | 0.060 ± 0.043 | 0.066 ± 0.032 | −6.7, .524 | 0.074 ± 0.017 | −10.8 | .209 |
Tb.Sp, mm | 1.072 ± 0.700 | 1.195 ± 0.791 | +1.2, .261 | 0.454 ± 0.125 | +163.2 | <.001 |
Tb.BV/TV, % | 6.5 ± 5.3 | 6.7 ± 5.0 | −9.9, .752 | 14.5 ± 4.2 | −53.8 | <.001 |
Ct.Th, mm | 0.71 ± 0.34 | 0.89 ± 0.26 | +13.8, .040 | 1.22 ± 0.32 | −27.0 | .009 |
Tibia . | Baseline . | Time C . | Median % increase between baseline and time C, p . | Control group . | Means difference . | p* . |
---|---|---|---|---|---|---|
Tb.vBMD, mgHA/cm3 | 88.8 ± 57.6 | 88.0 ± 49.8 | +2.0, .021 | 174.7 ± 50.5 | −49.6 | <.001 |
Ct.vBMD, mgHA/cm3 | 788.0 ± 120.3 | 840.1 ± 83.0 | +3.4, .049 | 881.6 ± 54.2 | −4.7 | .110 |
Tb.N, 1/mm | 1.12 ± 0.48 | 1.08 ± 0.56 | −0.2, .586 | 1.98 ± 0.42 | −45.4 | <.001 |
Tb.Th, mm | 0.060 ± 0.043 | 0.066 ± 0.032 | −6.7, .524 | 0.074 ± 0.017 | −10.8 | .209 |
Tb.Sp, mm | 1.072 ± 0.700 | 1.195 ± 0.791 | +1.2, .261 | 0.454 ± 0.125 | +163.2 | <.001 |
Tb.BV/TV, % | 6.5 ± 5.3 | 6.7 ± 5.0 | −9.9, .752 | 14.5 ± 4.2 | −53.8 | <.001 |
Ct.Th, mm | 0.71 ± 0.34 | 0.89 ± 0.26 | +13.8, .040 | 1.22 ± 0.32 | −27.0 | .009 |
Abbreviations: Tb.vBMD, trabecular density; Ct.vBMD, cortical density; Tb.N, trabecular number; Tb.Th, trabecular thickness; Tb.Sp, trabecular separation; Ct.Th, cortical thickness; Tb.BVTV, trabecular bone volume fraction.
*Comparison between time point C in patients with TIO (subgroup analysis of 10 patients with long-term follow-up) and control group.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.